Breast Cancer Clinical Trials in Zhejiang, Hangzhou
2 recruitingZhejiang, Hangzhou, China
Showing 1–2 of 2 trials
Recruiting
A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer
Breast Cancer
Zhejiang Cancer Hospital600 enrolled1 locationNCT07455188
Recruiting
Phase 2
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
Breast Cancer
Zhejiang Cancer Hospital118 enrolled1 locationNCT07330544